Intravenous Compared to Oral Busulfan with Cyclophosphamide for Autologous Hematopoietic Progenitor Cell Transplant Conditioning for Plasma Cell Myeloma

被引：0
|
作者：
Sobecks, Ronald [1 ]
Rybicki, Lisa [2 ]
Dean, Robert M. [1 ]
Abounader, Donna [1 ]
Andresen, S. [1 ]
Hien Duong [1 ]
Reu, Fred [1 ]
Bolwell, Brian [1 ]
Copelan, Ed [1 ]
Kalaycio, Matt E. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol & Blood Disorders, Cleveland, OH 44106 USA
[2] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2013年 / 19卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2012.11.192
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
152
引用
收藏
页码：S190 / S190
页数：1
相关论文
共 50 条
  • [31] Thiotepa, Busulfan, and Cyclophosphamide and Busulfan, Cyclophosphamide, Etoposide As Autologous Stem Cell Transplantation Conditioning Regimen in Primary Central Nervous System Lymphoma
    Hyung, Jaewon
    Hong, Jung Yong
    Yoon, Dok Hyun
    Lee, Kyoungmin
    Kim, Shin
    Park, Chan-Sik
    Huh, Jooryung
    Ryu, Jin-Sook
    Suh, Cheolwon
    BLOOD, 2017, 130
  • [32] Superior survival after replacing oral with intravenous busulfan in autologous stem cell transplantation for non-Hodgkin lymphoma with busulfan, cyclophosphamide and etoposide
    Dean, Robert M.
    Pohlman, Brad
    Sweetenham, John W.
    Sobecks, Ronald M.
    Kalaycio, Matt E.
    Smith, Stephen D.
    Copelan, Edward A.
    Andresen, Steven
    Rybicki, Lisa A.
    Curtis, Julie
    Bolwell, Brian J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (02) : 226 - 234
  • [33] High-Dose Melphalan Versus Busulfan, Cyclophosphamide As Conditioning Regimens for Hematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma
    Styler, Michael
    Crilley, Pamela Ann
    Jain, Maneesh
    Ward, Kristine
    Topolsky, David
    Cho, David
    Kim, Marc
    BLOOD, 2015, 126 (23)
  • [34] Icing oral mucositis: Oral cryotherapy in multiple myeloma patients undergoing autologous hematopoietic stem cell transplant
    Chen, Joey
    Seabrook, Jamie
    Fulford, Adrienne
    Rajakumar, Irina
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2017, 23 (02) : 116 - 120
  • [35] Gemcitabine, busulfan, and melphalan conditioning for autologous stem-cell transplants in multiple myeloma
    Gahrton, Gosta
    LANCET HAEMATOLOGY, 2017, 4 (06): : E250 - E251
  • [36] Busulfan and thiotepa as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Song, Ga-Young
    Jung, Sung-Hoon
    Kim, Mihee
    Ahn, Seo-Yeon
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Kim, Hyeong-Joon
    Kim, Jin Seok
    Eom, Hyeon-Seok
    Moon, Joon Ho
    Yhim, Ho-Young
    Kim, Kihyun
    Min, Chang-Ki
    Lee, Je-Jung
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S157 - S158
  • [37] Busulfan and thiotepa conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma
    Jung, Sung-Hoon
    Ahn, Seo-Yeon
    Yang, Deok-Hwan
    Kim, Hyeoung-Joon
    Kim, Jin Seok
    Kim, Kihyun
    Eom, Hyeon-Seok
    Yhim, Ho-Young
    Lee, Yoo Jin
    Hyun, Shin Young
    Lee, Je-Jung
    BONE MARROW TRANSPLANTATION, 2019, 54 : 226 - 226
  • [38] Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial
    Claire Seydoux
    Michael Medinger
    Sabine Gerull
    Joerg Halter
    Dominik Heim
    Yves Chalandon
    Stavroula Masouridi Levrat
    Urs Schanz
    Gayathri Nair
    Marc Ansari
    Patrick Simon
    Jakob R. Passweg
    Nathan Cantoni
    Annals of Hematology, 2021, 100 : 209 - 216
  • [39] Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial
    Seydoux, Claire
    Medinger, Michael
    Gerull, Sabine
    Halter, Joerg
    Heim, Dominik
    Chalandon, Yves
    Levrat, Stavroula Masouridi
    Schanz, Urs
    Nair, Gayathri
    Ansari, Marc
    Simon, Patrick
    Passweg, Jakob R.
    Cantoni, Nathan
    ANNALS OF HEMATOLOGY, 2021, 100 (01) : 209 - 216
  • [40] Busulfan-Cyclophosphamide versus Cyclophosphamide-Busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial
    Seydoux, C.
    Medinger, M.
    Gerull, S.
    Halter, J.
    Heim, D.
    Chalandon, Y.
    Levrat, Masouridi S.
    Schanz, U.
    Nair, G.
    Simon, P.
    Passweg, J. R.
    Cantoni, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 45 - 46
12345